Trisha Roy

McKesson to replace some Moderna COVID-19 vaccines due to low temperature

Jan 20 2021

McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said on Wednesday.

Moderna CEO confident of producing 500 million COVID-19 vaccine doses in 2021

Dec 04 2020

Moderna Inc will be able to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Executive Officer Stéphane Bancel said on Friday.

Becton Dickinson sees COVID-19 test sales of up to $1.5 billion after profit beat

Nov 05 2020

Medical device maker Becton Dickinson and Co said on Thursday it expects as much as $1.5 billion in sales from its COVID-19 diagnostic test next year, after reporting a quarterly profit that beat Wall Street estimates.

Medtronic under Justice Department probe over ventilator competition: WSJ

Oct 01 2020

(This September 30 story corrects paragraph 4 to say probe is only on Covidien-Newport deal)

U.S. states seek $26.4 billion from drug firms in opioid litigation: WSJ

Aug 18 2020

U.S. states are seeking a combined $26.4 billion from three major drug distributors and Johnson & Johnson to settle opioid litigation against the companies, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Boston Scientific sees improved July trends as elective surgery recovers

Jul 29 2020

Medical device maker Boston Scientific Corp on Wednesday posted a surprise adjusted quarterly profit and said demand for elective procedures picked up pace in July following an easing of coronavirus-driven restrictions.

Walgreens CEO Stefano Pessina to step down

Jul 27 2020

Walgreens Boots Alliance Inc said on Monday its biggest shareholder, Stefano Pessina, will step down as the chief executive officer after five years at the helm, during which the pharmacy group's value more than halved.

Biogen lifts full-year profit forecast as Tecfidera boosts quarter

Jul 22 2020

Biogen Inc raised its 2020 earnings forecast on Wednesday after better-than-expected sales of its multiple sclerosis treatment Tecfidera helped the drugmaker beat second-quarter profit estimates.

Abbott sees no hit to demand for COVID-19 tests from vaccine

Jul 16 2020

Abbott Laboratories said on Thursday demand for its coronavirus tests will likely remain high even after a safe and effective vaccine is available as the medical device maker forecast full-year profit above analysts' estimates.

World News